UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
Current Report Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event Reported): April 27, 2011
THERAVANCE, INC.
(Exact Name of Registrant as Specified in its Charter)
Delaware |
| 000-30319 |
| 94-3265960 |
(State or Other Jurisdiction of |
| (Commission File Number) |
| (I.R.S. Employer Identification Number) |
901 Gateway Boulevard
South San Francisco, California 94080
(650) 808-6000
(Addresses, including zip code, and telephone numbers, including area code, of principal executive offices)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07 Submission of Matters to a Vote of Security Holders.
(a) The Annual Meeting of Stockholders of Theravance, Inc. was held on April 27, 2011.
(b) The nominees listed below were elected directors with the respective votes set forth opposite their names:
|
| Votes for |
| Votes withheld |
|
Rick E Winningham |
| 69,933,385 |
| 2,607,155 |
|
Jeffrey M. Drazan |
| 70,048,547 |
| 2,491,993 |
|
Henrietta Holsman Fore |
| 70,827,772 |
| 1,712,768 |
|
Robert V. Gunderson, Jr. |
| 69,593,678 |
| 2,946,862 |
|
Arnold J. Levine. Ph.D |
| 70,271,418 |
| 2,269,122 |
|
Burton G. Malkiel, Ph.D. |
| 69,506,003 |
| 3,034,537 |
|
Peter S. Ringrose, Ph.D. |
| 71,667,912 |
| 872,628 |
|
William H. Waltrip |
| 70,131,896 |
| 2,408,644 |
|
George M. Whitesides, Ph.D |
| 69,914,329 |
| 2,626,211 |
|
William D. Young |
| 70,323,341 |
| 2,217,199 |
|
The stockholders also approved an amendment to the Company’s 2004 Employee Stock Purchase Plan increasing the aggregate number of shares of common stock authorized for issuance thereunder by 550,000 shares. The voting results are set forth below:
For |
| Against |
| Abstain |
|
72,265,420 |
| 207,677 |
| 67,443 |
|
The voting results on a non-binding advisory vote to approve the compensation of the Company’s named executive officers disclosed in the Company’s 2011 proxy statement are set forth below:
For |
| Against |
| Abstain |
|
71,534,583 |
| 919,780 |
| 86,177 |
|
The voting results on a non-binding advisory vote on the frequency of the advisory vote on executive compensation are set forth below:
One Year |
| Two Years |
| Three Years |
| Abstain |
|
67,482,840 |
| 120,481 |
| 4,869,596 |
| 67,623 |
|
In light of these results, the Board of Directors has determined to hold an annual advisory vote on executive compensation.
The stockholders also ratified the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2011. The voting results are set forth below:
For |
| Against |
| Abstain |
|
77,579,400 |
| 362,526 |
| 7,107 |
|